What to know about new GLP-1 warning on possible vision loss

Chronological Source Flow
Back

AI Fusion Summary

The FDA has added a rare vision‑loss warning to popular GLP‑1 weight‑loss drugs such as Ozempic and Wegovy, citing mixed data on the risk. While the danger appears small, regulators urge patients to be aware of possible side effects. The announcement follows growing scrutiny of these medications' safety profiles in the United States.
Community Comments
Loading updates...
0